Article
Albuminuria Changes as a surrogate endpoint in <i>Apolipoprotein L1</i> Mediated Kidney Disease in Vanderbilt BioVU and the Million Veteran Program
2026-06-08
Abstract excerpt
<h4>Importance</h4> Recently, proteinuria has been accepted as a surrogate end point for clinical trials in focal segmental glomerulosclerosis (FSGS) ang IgA nephropathy. However, proteinuria has not been evaluated in Apolipoprotein L1 (APOL1)-mediated kidney disease (AMKD). <h4>Methods</h4> Real world data (RWD) analysis of 128 patients of African ancestry with APOL1 high risk genotypes, without diabetes, enrol...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 603b9298-2b8c-5cfd-bf95-07091a072b04
- DOI
- 10.64898/2026.06.04.26354945
